Pneumococcal Conjugated Vaccine 13 (PCV13) for Patients With Multiple Myeloma (MM)
Clinical trial NCT07154537 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07154537
- Sponsor
- National Taiwan University Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-23
- Primary completion
- 2024-04-03
- Enrollment
- 101
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.